http://www.guardian.co.uk/medicine/s...080258,00.html
The problem is more than just newer drugs, though. One of the cancers where the performance has been relatively poor is bowel cancer (usually called colon cancer in the US), but of course it because the screening program is almost non-existent. I think we would all agree that finding cancer before it needs chemo is more important and a better use of money.